Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial.
Journal: The Lancet. Haematology
Published: June 19, 2024
Patterns and Predictors of Hydroxyurea Use Among Californians Living With Sickle Cell Disease.
Journal: Journal of pediatric hematology/oncology
Published: April 02, 2024
Targeting TRPV1 activity via high-dose capsaicin in patients with sickle cell disease.
Journal: EJHaem
Published: June 23, 2022
Prophylactic Hydroxyurea Treatment Is Associated with Improved Cerebral Hemodynamics as a Surrogate Marker of Stroke Risk in Sickle Cell Disease: A Retrospective Comparative Analysis.
Journal: Journal of clinical medicine
Published: May 23, 2022
A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease.
Journal: Orphanet journal of rare diseases
Published: June 09, 2021
Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor.
Journal: Therapeutic advances in hematology
Published: February 13, 2021
Neuropathic pain in sickle cell disease: measurement and management.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 04, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026